Chimeric antigen receptor–based cell therapy for treating urological tumors
Abstract. Urological tumors represent a significant global health challenge, with conventional therapies often proving insufficient to control disease progression. Recent breakthroughs in cellular immunotherapy, particularly in chimeric antigen receptor (CAR)-T cell, CAR–natural killer cell, and CAR...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer Health
2025-11-01
|
| Schriftenreihe: | Current Urology |
| Online-Zugang: | http://journals.lww.com/10.1097/CU9.0000000000000305 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|